Seminars in Diagnostic Pathology
Volume 27, Issue 1 , Pages 37-48 , February 2010

Flat ductal intraepithelial neoplasia of the breast: evolution of Azzopardi's “clinging” concept

  • Farid Moinfar, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Farid Moinfar, MD, Unit of Breast and Gynecologic Pathology, Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25 A-8036 Graz, Austria.

References 

  1. Azzopardi JG. Problems in Breast Pathology. In: London, United Kingdom: W. B. Saunders Company; 1979;p. 193–203
  2. Moinfar F. Essentials of Diagnostic Breast Pathology. Heidelberg, Germany: Springer; 2007;
  3. International Histological Classification of Tumours. Histological Typing of Breast Tumours. (ed 2). Geneva, Switzerland: World Health Organization; 1981;
  4. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol. 1994;11:167–180
  5. Tavassoli FA. Pathology of the Breast. (ed 1). Norwalk, Connecticut: Appleton & Lange; 1992;
  6. Moinfar F, Man YG, Bratthauer GL, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (“clinging ductal carcinoma in situ”): A simulator of normal mammary epithelium. Cancer. 2000;88:2072–2081
  7. Fernandez-Aguilar S, Simon P, Buxant F, et al. Tubular carcinoma of the breast and associated intraepithelial lesions: A comparative study with invasive low-grade ductal carcinomas. Virchows Arch. 2005;447:683–687
  8. Sahoo S, Recant WM. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast. Breast J. 2005;11:140–142
  9. Leibl S, Regitnig P, Moinfar F. Flat epithelial atypia (DIN1a, atypical columnar change): An underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology. 2007;50:859–865
  10. Abdel-Fatah TMA, Powe DG, Hodi Z, et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31:417–426
  11. Oyama T, Lijima K, Takei H, et al. Atypical cystic lobules of the breast: An early stage of low-grade ductal carcinoma in situ. Breast Cancer. 2000;7:326–331
  12. Brogi E, Oyama T, Koerner FC. Atypical cystic lobules in patients with lobular neoplasia. Int J Surg Pathol. 2001;9:201–206
  13. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special references to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231–273
  14. Tsuchiya S. Atypical ductal hyperplasia, atypical lobular hyperplasia, and interpretation of a new borderline lesion. Jpn J Cancer Clin. 1998;44:548–555
  15. Kusama R, Fujimori M, Matsuyama I, et al. Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: Assessment of ACD as a precancerous lesion. Pathol Int. 2000;50:793–800
  16. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003;10:113–124
  17. Simpson PT, Gale T, Reis-Filho JS, et al. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005;29:734–746
  18. Tan PH, Ho BC-S, Selvarajan S, et al. Pathological diagnosis of columnar cell lesions of the breast: Are there issues of reproducibility?. J Clin Pathol. 2008;58:705–709
  19. Fraser JL, Raza S, Chorny K, et al. Columnar alteration with prominent apical snouts and secretions: A spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521–1527
  20. Frazer JL, Raza S, Chorny K, et al. Immunophenotype of columnar alteration with prominent apical snouts and secretions (abstract). Lab Invest. 2000;80:21A
  21. Dessauvagie B, Zhao W, Heel-Miller KA, et al. Characterization of columnar cell lesion of the breast: Immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretion. Hum Pathol. 2007;38:284–292
  22. Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999;23:1561
  23. Rosen PP. Breast Pathology. (ed 2). Philadelphia, PA: Lippincott Williams & Wilkins; 2001;
  24. Nasser SM, Fan MJ. Does atypical columnar cell hyperplasia on breast core biopsy warrant follow-up excision?. (abstract) Mod Pathol. 2003;16:42A
  25. Nasser SM. Columnar cell lesions: Current classification and controversies. Semin Diagn Pathol. 2004;21:18–24
  26. Goldstein NS, O'Malley BA. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts (A lesion associated with tubular carcinoma). Am J Clin Pathol. 1997;107:561–566
  27. Bratthauer G, Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch. 2004;444:340–344
  28. Schnitt SJ. Flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res. 2003;5:263–268
  29. O'Malley F, Mohsen S, Badve S, et al. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006;19:172–179
  30. Kunju LP, Kleer CG. Significance of flat epithelial atypia on mammotome core needle bioposy: Should it be excised?. Hum Pathol. 2007;38:35–41
  31. McLaren BK, Gobbi H, Schuyler PA, et al. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies (A nested case-control study). Am J Surg Pathol. 2005;29:105–108
  32. Tavassoli FA, Hoefler H, Rosai J, et al. Intraductal proliferative lesions. In:  Tavassoli FA,  Devilee P editor. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. Lyon, France: Iarcpress; 2003;
  33. Noel JC, Fayt I, Fernandez-Aguilar S, et al. Proliferating activity in columnar cell lesions of the breast. Virchows Arch. 2006;449:617–621
  34. Dabbs DJ, Carter G, Fudge M, et al. Molecular alterations in columnar cell lesions of the breast. Mod Pathol. 2006;19:344–349
  35. Dutrillaux B, Gerbault-Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer. Cancer Genet Cytogenet. 1990;49:203–217
  36. Kokalj-Vokac N, Alemeide A, Gerbault-Seureau M, et al. Two-color FISH characterization of i(1q) and der(1;16) in human breast cancer cells. Genes Chromosomes Cancer. 1993;7:8–14
  37. Eusebi V, Foschini MP, Cook MG, et al. Long-term follow-up of in situ carcinoma of the breast with special emphasize on clinging carcinoma. Semin Diagn Pathol. 1989;6:165–193
  38. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19:2263–2271
  39. Boulos F, Dupont WD, Simpson JF, et al. Histologic associations and long-term cancer risk in columnar cell lesions of the breast (A retrospective cohort and nested case-control study). Cancer. 2008;113:2415–2421
  40. Tavassoli FA, Norris HJ. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer. 1990;65:518–529
  41. Bodian CA, Perzin KH, Lattes R, et al. Prognostic significance of benign proliferative breast disease. Cancer. 1993;71:3896–3907
  42. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol. 1987;125:769–779
  43. Krieger N, Hiatt RA. Risk of breast cancer after benign breast diseases (Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up). Am J Epidemiol. 1992;135:619–631
  44. Bonnet M, Wallis T, Rossmann M, et al. Histologic analysis of atypia diagnosed on needle core breast biopsies (abstract). Mod Pathol. 2002;15:29A–30A
  45. Brogi E, Tan LK. Findings an excisional biopsy (EBX) performed after identification of columnar cell change (CCC) of ductal epithelium in breast core biopsy (CBX) (abstract). Mod Pathol. 2002;15:29A–30A
  46. Guerra-Wallace MM, Christensen WN, White RL. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg. 2004;188:395–398
  47. Kunju LP, Kleer CG. Significance of flat epithelial atypia (FEA) on mammotome core needle biopsy: Should it be excised?. (abstract) Mod Pathol. 2006;19:32A
  48. Martel M, Barron-Rodriguez P, Ocal IT, et al. Flat DIN1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1751 core biopsies performed over an 8-year period (1992-1999). Virchows Arch. 2007;451:883–891
  49. Mascarel I, MacGrogan G, Mathoulin-Pelissier S, et al. Epithelial atypia in biopsies performed for microcalcifications (Practical considerations about 2833 serially sectioned surgical biopsies with long follow-up). Virchows Arch. 2007;451:1–10

PII: S0740-2570(09)00095-1

doi: 10.1053/j.semdp.2009.12.005

Seminars in Diagnostic Pathology
Volume 27, Issue 1 , Pages 37-48 , February 2010

Article Tools

* Image Usage & Resolution